Two-Color Cell Array Screen Reveals Interdependent Roles for Histone Chaperones and a Chromatin Boundary Regulator in Histone Gene Repression
Open accessAbstract
We describe a fluorescent reporter system that exploits the functional genomic tools available in budding yeast to systematically assess consequences of genetic perturbations on gene expression. We used our Reporter-Synthetic Genetic Array (R-SGA) method to screen for regulators of core histone gene expression. We discovered that the histone chaperone Rtt106 functions in a pathway with two other chaperones, Asf1 and the HIR complex, to create a repressive chromatin structure at core histone promoters. We found that activation of histone (HTA1) gene expression involves both relief of Rtt106-mediated repression by the activity of the histone acetyltransferase Rtt109 and restriction of Rtt106 to the promoter region by the bromodomain-containing protein Yta7. We propose that the maintenance of Asf1/HIR/Rtt106-mediated repressive chromatin domains is the primary mechanism of cell-cycle regulation of histone promoters. Our data suggest that this pathway may represent a chromatin regulatory mechanism that is broadly used across the genome.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Rtt106 recruitment to the histone promoters almost completely depends on Asf1, HIR and acetylation of histone H3 at K56 (H3K56Ac), and is limited by Yta7.
“Rtt106 recruitment to the histone promoters almost completely depends on Asf1, HIR and acetylation of histone H3 at K56 (H3K56Ac), and is limited by Yta7, a bromodomain- and AAA-ATPase domain-containing boundary protein31,32,35.”
From SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes (2022) · cites this paper as [31]
Outside S phase, Rtt106 forms a repressive complex together with other histone chaperones HIR and Asf1 to recruit RSC to the histone promoters.
“Outside S phase, Rtt106 forms a repressive complex together with other histone chaperones HIR and Asf1 to recruit RSC (Remodel the Structure of Chromatin), an essential ATP-dependent chromatin-remodelling complex, to the histone promoters31–33.”
From SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes (2022) · cites this paper as [31]
Rtt106 localises at the promoters of three out of four histone gene pairs (HTA1-HTB1, HHT1-HHF1 and HHT2-HHF2, but not HTA2-HTB2) and restricts their transcription to S phase.
“Rtt106 localises at the promoters of three out of four histone gene pairs (HTA1-HTB1, HHT1-HHF1 and HHT2-HHF2, but not HTA2-HTB2), and restricts their transcription to S phase, when new histone supply is required to package newly synthesised DNA31,32.”
From SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes (2022) · cites this paper as [31]
Yta7 limits Rtt106 binding at the PDRE-containing promoters.
“We further observed that Yta7, a boundary protein that restricts Rtt106 binding at the histone promoters31,32 (Fig. 2b, yta7Δ), limits Rtt106 binding also at the PDRE-containing promoters, as loss of Yta7 increased Rtt106 binding (Fig. 2a, yta7Δ).”
From SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes (2022) · cites this paper as [31]
The difference in histone gene effects may reflect the fact that we prepared RNA from asynchronous cells rather than cells at specific cell-cycle stages.
“This difference may reflect the fact that we prepared RNA from asynchronous cells rather than cells at specific cell-cycle stages31,32.”
From SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes (2022) · cites this paper as [31]
In our experiments, only HHF1 mRNA was significantly increased in rtt106Δ, unlike previous reports which found additional histone genes affected.
“Regarding histone gene expression, in our experiments only HHF1 mRNA was significantly increased in rtt106Δ (Fig. 3a and Supplementary Data 3), unlike previous reports which found additional histone genes affected31,32.”
From SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes (2022) · cites this paper as [31]
At the histone promoters, RTT106 deletion causes further reduction of nucleosome occupancy.
“At the histone promoters, RTT106 deletion causes further reduction of nucleosome occupancy as reported previously31 (Fig. 2g, Type B, compare green dashed line with solid line).”
From SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes (2022) · cites this paper as [31]
The HIR histone chaperone contributes to Rtt106 recruitment to PDRE-containing promoters.
“We observed that the HIR histone chaperone, a crucial factor for recruitment of Rtt106 to the HTA1-HTB1 promoter31,32 (Fig. 2b, hir1Δ), contributes to Rtt106 recruitment to PDRE-containing promoters, since the loss of the HIR subunit Hir1 caused a reduction of Rtt106 binding (Fig. 2a, hir1Δ).”
From SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes (2022) · cites this paper as [31]
Rtt106 localises at the promoter of the histone gene pair HTA1-HTB1 in S. cerevisiae.
“As expected31,32, Rtt106 localised at the promoter of the histone gene pair HTA1-HTB1 (Fig. 1a).”
From SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes (2022) · cites this paper as [31]
The citation lists haven’t been fetched yet
References 44 · Cited by 108
- Authors
- Fillingham, J., Kainth, P., Lambert, J.-P., van Bakel, H., Tsui, K., Peña-Castillo, L., Nislow, C., Figeys, D., Hughes, T. R., Greenblatt, J., & Andrews, B. J.
- Affiliations
- University of Toronto (CA)
- University of Ottawa (CA)
- Corresponding author
- Andrews, Brenda J.
- ORCID
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 35
- Issue
- 3
- Pages
- 340-351
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2020673367
- Cited by
- 108
- References
- 44
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 15 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 4 · 2015: 1 · 2014: 8 · 2013: 8 · 2012: 12
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Genome Canada
- Ontario Genomics Institute
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- histone chaperone, Asf1, Rtt109, histone acetyltransferase, chromatin boundaries, cell cycle regulation, Saccharomyces cerevisiae
- MeSH terms
- Chromosomal Proteins, Non-Histone, Gene Expression Regulation, Histones, Nuclear Proteins, Promoter Regions, Genetic, Repressor Proteins, Saccharomyces cerevisiae, Genome, Fungal, Genes, Reporter, Cell Cycle Proteins, Molecular Chaperones, Genomics, Saccharomyces cerevisiae Proteins, Histone Acetyltransferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review